Free Trial
LON:ARIX

Arix Bioscience (ARIX) Share Price, News & Analysis

Arix Bioscience logo

About Arix Bioscience Stock (LON:ARIX)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
142
142
52-Week Range
N/A
Volume
377,046 shs
Average Volume
636,934 shs
Market Capitalization
£183.73 million
P/E Ratio
1,290.91
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive ARIX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Arix Bioscience and its competitors with MarketBeat's FREE daily newsletter.

ARIX Stock News Headlines

ARIX/USD - Arix US Dollar
Presidential Bombshell: $150T Resource to Be Released as soon as this Summer?
Something extraordinary is happening in Washington. For the first time in over a century, a sitting President could release a national treasure that's been tied up in red tape, for generations. I'm talking about a $150 trillion American asset that's scattered across all 50 states. While the mainstream media focuses on political theater, this story is quietly developing behind closed doors.
Arix Bioscience PLC (3HY.SG)
See More Headlines

ARIX Stock Analysis - Frequently Asked Questions

Shares of ARIX stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that Arix Bioscience investors own include Eagle Point Credit (ECC), Venture Life Group (VLG), Antero Resources (AR), Bango (BGO), BATM Advanced Communications (BVC), Gresham House (GHE) and Ivanhoe Mines (IVN).

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
LON:ARIX
CIK
N/A
Fax
N/A
Employees
9
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
GBX 0.11
Trailing P/E Ratio
1,290.91
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
£14.96 million
Net Margins
105.64%
Pretax Margin
N/A
Return on Equity
6.41%
Return on Assets
2.18%

Debt

Debt-to-Equity Ratio
0.01
Current Ratio
73.10
Quick Ratio
117.67

Sales & Book Value

Annual Sales
£14.16 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
1.04
Book Value
GBX 192 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
129,390,000
Free Float
N/A
Market Cap
£183.73 million
Optionable
Not Optionable
Beta
1.05
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

This page (LON:ARIX) was last updated on 7/19/2025 by MarketBeat.com Staff
From Our Partners